MA41985B1 - Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux - Google Patents

Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux

Info

Publication number
MA41985B1
MA41985B1 MA41985A MA41985A MA41985B1 MA 41985 B1 MA41985 B1 MA 41985B1 MA 41985 A MA41985 A MA 41985A MA 41985 A MA41985 A MA 41985A MA 41985 B1 MA41985 B1 MA 41985B1
Authority
MA
Morocco
Prior art keywords
gastrointestinal disorders
cleansing
colon
composition
treating gastrointestinal
Prior art date
Application number
MA41985A
Other languages
English (en)
French (fr)
Other versions
MA41985A (fr
Inventor
Mark Currie
Robert Solinga
Christopher Leitheiser
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of MA41985A publication Critical patent/MA41985A/fr
Publication of MA41985B1 publication Critical patent/MA41985B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA41985A 2015-05-01 2016-04-29 Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux MA41985B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
PCT/US2016/030061 WO2016178979A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Publications (2)

Publication Number Publication Date
MA41985A MA41985A (fr) 2018-03-07
MA41985B1 true MA41985B1 (fr) 2023-04-28

Family

ID=55953439

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41985A MA41985B1 (fr) 2015-05-01 2016-04-29 Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux

Country Status (23)

Country Link
US (2) US10618938B2 (https=)
EP (2) EP3288578B8 (https=)
JP (5) JP6930919B2 (https=)
KR (2) KR20250042844A (https=)
CN (2) CN108040482B (https=)
CA (2) CA3172777A1 (https=)
CY (1) CY1126031T1 (https=)
DK (1) DK3288578T5 (https=)
EA (1) EA201792401A1 (https=)
ES (1) ES2947591T3 (https=)
FI (1) FI3288578T3 (https=)
HR (1) HRP20230381T1 (https=)
HU (1) HUE061954T2 (https=)
LT (1) LT3288578T (https=)
MA (1) MA41985B1 (https=)
MD (1) MD3288578T2 (https=)
MX (2) MX2017013928A (https=)
PL (1) PL3288578T3 (https=)
PT (1) PT3288578T (https=)
RS (1) RS64160B1 (https=)
SI (1) SI3288578T1 (https=)
SM (1) SMT202300114T1 (https=)
WO (1) WO2016178979A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2947591T3 (es) * 2015-05-01 2023-08-11 Ironwood Pharmaceuticals Inc Composiciones para la limpieza del colon y el tratamiento de trastornos gastrointestinales
EP4067368A1 (en) 2016-06-01 2022-10-05 Athira Pharma, Inc. Compounds
IL312992A (en) * 2021-11-24 2024-07-01 Ironwood Pharmaceuticals Inc A synthetic process for the production of modified GCC receptor agonists
CN118696053A (zh) * 2021-11-24 2024-09-24 硬木药品公司 用于产生修饰的gcc受体激动剂的合成方法
IL313184A (en) * 2021-11-29 2024-07-01 Ironwood Pharmaceuticals Inc Pharmaceutical compositions for the treatment of visceral pain
WO2026050206A1 (en) * 2024-08-27 2026-03-05 Ironwood Pharmaceuticals, Inc. Combinations of glp-1 and guanylate cyclase c (gc-c) receptor agonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
SG168407A1 (en) * 2003-01-28 2011-02-28 Ironwood Pharmaceuticals Inc Methods and compositions for the treatment of gastrointestinal disorders
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
EP1940441A4 (en) * 2005-08-19 2010-01-27 Ironwood Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
WO2010025510A1 (en) * 2008-09-03 2010-03-11 Xenome Ltd Libraries of peptide conjugates and methods for making them
US8933030B2 (en) * 2010-02-17 2015-01-13 Ironwwod Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
ES2664873T3 (es) * 2011-03-01 2018-04-23 Synergy Pharmaceuticals Inc. Proceso de preparación de agonistas de guanilato ciclasa C
US9545446B2 (en) * 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
SI3004138T1 (sl) * 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
WO2016015055A1 (en) * 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
ES2947591T3 (es) * 2015-05-01 2023-08-11 Ironwood Pharmaceuticals Inc Composiciones para la limpieza del colon y el tratamiento de trastornos gastrointestinales

Also Published As

Publication number Publication date
DK3288578T3 (da) 2023-05-01
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
US10618938B2 (en) 2020-04-14
EP4218789A3 (en) 2023-09-27
EA201792401A1 (ru) 2018-05-31
US20180148476A1 (en) 2018-05-31
CN108040482A (zh) 2018-05-15
US20240199697A1 (en) 2024-06-20
MX2022013283A (es) 2022-12-13
CA2984437C (en) 2025-11-18
EP3288578B1 (en) 2023-03-15
KR102783759B1 (ko) 2025-03-21
EP3288578A1 (en) 2018-03-07
PL3288578T3 (pl) 2023-08-14
CA2984437A1 (en) 2016-11-10
HRP20230381T1 (hr) 2023-07-07
JP2018519254A (ja) 2018-07-19
JP6930919B2 (ja) 2021-09-01
JP2022121734A (ja) 2022-08-19
ES2947591T3 (es) 2023-08-11
CA3172777A1 (en) 2016-11-10
HUE061954T2 (hu) 2023-09-28
PT3288578T (pt) 2023-03-28
LT3288578T (lt) 2023-04-25
EP3288578B8 (en) 2023-03-29
RS64160B1 (sr) 2023-05-31
KR20250042844A (ko) 2025-03-27
BR112017023539A2 (pt) 2018-08-14
SMT202300114T1 (it) 2023-05-12
JP2024015335A (ja) 2024-02-01
CY1126031T1 (el) 2023-11-15
MD3288578T2 (ro) 2023-08-31
FI3288578T3 (fi) 2023-05-03
CN108040482B (zh) 2022-03-29
CN114716514A (zh) 2022-07-08
KR20180005675A (ko) 2018-01-16
JP2025169325A (ja) 2025-11-12
SI3288578T1 (sl) 2023-07-31
JP2020203954A (ja) 2020-12-24
DK3288578T5 (da) 2024-10-07
EP4218789A2 (en) 2023-08-02
WO2016178979A1 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
MA41985B1 (fr) Composition pour le nettoyage du côlon et le traitement de troubles gastro-intestinaux
MX2024008539A (es) Compuestos bifuncionales para degradar la tirosina cinasa de bruton (btk) mediante la trayectoria de ubiquitina proteosoma.
EA201290322A1 (ru) Лечение желудочно-кишечных расстройств
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
EA201170036A1 (ru) Соединения боронатного эфира и его фармацевтические составы
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
EP1881823A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF EYE DISEASES
EA201691242A1 (ru) Фармацевтические композиции, содержащие azd9291
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
MA44426B1 (fr) Compositions et méthodes pour diminier l'expression de tau
EA201071291A2 (ru) Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
EA201790653A1 (ru) Способ лечения болезни альцгеймера и других расстройств
EA201290860A1 (ru) Лечение ревматоидного артрита комбинацией лаквинимода и метотрексата
MA39359A1 (fr) Composés d'isoindolinone utilisés comme modulateurs de gpr119 pour le traitement du diabète, de l'obésité et de troubles associés
MX2022000712A (es) Moduladores de nlrp3.
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
EA202192925A1 (ru) Твердые формы ингибитора glyt1
BR112012032215A2 (pt) composição farmacêutica líquida compreendendo imunoglobulinas g humanas (iggs) e composição sólida
EA201171035A1 (ru) Композиции, включающие модуляторы pde4, и способ их применения для лечения, профилактики и сопровождения туберкулеза
EA202190057A1 (ru) Солюбилизированные апиразы, способы и применение
BRPI0907220A2 (pt) métodos de tratar distúrbios de perda óssea usando um antagonista de gm-csf
NO20084190L (no) Anvendelse av VX-702 til behandling av revmatoid artritt